Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Gains from Sales and Divestitures (2021 - 2023)

Historic Gains from Sales and Divestitures for Pasithea Therapeutics (KTTA) over the last 2 years, with Q4 2023 value amounting to $5832.0.

  • Pasithea Therapeutics' Gains from Sales and Divestitures changed N/A to $5832.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $5832.0, marking a year-over-year change of. This contributed to the annual value of $5832.0 for FY2023, which is N/A changed from last year.
  • Pasithea Therapeutics' Gains from Sales and Divestitures amounted to $5832.0 in Q4 2023.
  • Pasithea Therapeutics' Gains from Sales and Divestitures' 5-year high stood at $100000.0 during Q4 2021, with a 5-year trough of $5832.0 in Q4 2023.